Article Text
Abstract
Overdiagnosis is an emerging problem in health policy and practice: we address its definition and ethical implications. We argue that the definition of overdiagnosis should be expressed at the level of populations. Consider a condition prevalent in a population, customarily labelled with diagnosis A. We propose that overdiagnosis is occurring in respect of that condition in that population when (1) the condition is being identified and labelled with diagnosis A in that population (consequent interventions may also be offered); (2) this identification and labelling would be accepted as correct in a relevant professional community; but (3) the resulting label and/or intervention carries an unfavourable balance between benefits and harms. We identify challenges in determining and weighting relevant harms, then propose three central ethical considerations in overdiagnosis: the extent of harm done, whether harm is avoidable and whether the primary goal of the actor/s concerned is to benefit themselves or the patient, citizen or society. This distinguishes predatory (avoidable, self-benefiting), misdirected (avoidable, other-benefiting) and tragic (unavoidable, other-benefiting) overdiagnosis; the degree of harm moderates the justifiability of each type. We end with four normative challenges: (1) methods for adjudicating between professional standards and identifying relevant harms and benefits should be procedurally just; (2) individuals, organisations and states are differently responsible for addressing overdiagnosis; (3) overdiagnosis is a matter for distributive justice: the burdens of both overdiagnosis and its prevention could fall on the least-well-off; and (4) communicating about overdiagnosis risks harming those unaware that they may have been overdiagnosed. These challenges will need to be addressed as the field develops.
- Public Health Ethics
- Philosophy of Medicine
Statistics from Altmetric.com
Footnotes
Twitter Follow Stacy Carter at @stacymcarter
Contributors SMC led the analysis and writing. All four authors contributed to the development of the argument, through a collaborative, iterative process.
Funding National Health and Medical Research Council (1023197) and (1032963).
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Linked Articles
- Commentary
- Commentary
- Commentary
- Response
Read the full text or download the PDF:
Other content recommended for you
- Defining and evaluating overdiagnosis
- Casting the net too wide on overdiagnosis: benefits, burdens and non-harmful disease
- A definition and ethical evaluation of overdiagnosis: response to commentaries
- Should women aged 70–74 be invited to participate in screening mammography? A report on two Australian community juries
- Public perceptions of changing the terminology for low - risk thyroid cancer: a qualitative focus group study
- Overdiagnosis in primary care: framing the problem and finding solutions
- Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach
- How different terminology for ductal carcinoma in situ impacts women 's concern and treatment preferences: a randomised comparison within a national community survey
- What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries
- Evaluation of the overdiagnosis in breast screening programmes using a Monte Carlo simulation tool: a study of the influence of the parameters defining the programme configuration